The Effects of PCSO-524 Extract on Vital Signs, Complete Blood Count, and Blood Chemistry in Clinically-Healthy Normal Cats June 26, 2024June 26, 2024 | Vetz Petz Antinol
Effects of Dietary Polyunsaturated Fatty Acid Supplement on Healthy Beagle Dogs June 26, 2024June 26, 2024 | Vetz Petz Antinol
Preliminary Study on Treatment Outcomes and Prednisolone Tapering after Marine Lipid Extract EAB-277 Supplementation in Dogs with Immune-Mediated Hemolytic Anemia June 26, 2024June 26, 2024 | Vetz Petz Antinol
Effect of PCSO-524 on OA Biomarkers and Weight-Bearing Properties in Canine Shoulder and Coxofemeral Osteoarthritis June 26, 2024June 26, 2024 | Vetz Petz Antinol
Clinical studies basics – What are clinical trials, why do we do them, and how do I know if they’re good? June 25, 2024June 26, 2024 | Vetz Petz Antinol
Clinical study comparing Antinol+® and Antinol® with Rimadyl® and glucosamine and chondroitin for the treatment of dogs with osteoarthritis March 27, 2024June 26, 2024 | Vetz Petz Antinol
The effectiveness of marine-based fatty acid compound (PCSO-524) and firocoxib in the treatment of canine osteoarthritis March 27, 2024June 26, 2024 | Vetz Petz Antinol
Oclacitinib and PCSO-524 in dogs with atopic dermatitis March 27, 2024June 26, 2024 | Vetz Petz Antinol
Effectiveness of disease modifying osteoarthritis agents and carprofen for treatment of canine osteoarthritis March 27, 2024June 26, 2024 | Vetz Petz Antinol
